AgeX Therapeutics, Inc. (AGE)

EBITDA Margin

-13211.54%

TTM · Period ending:

AGE logo

AGE EBITDA Margin

Latest reported-13211.54%
AGE EBITDA Margin (-675.85% → -13211.54%)
High-resolution chart · PNG

AGE ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
56.1538%
346.4286%
-6,835.9155%
-20,750%
-5,106.9444%
-471.7345%
-671.7593%
-767.192%
-675.8547%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.